Compare IRTC & FIZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRTC | FIZZ |
|---|---|---|
| Founded | 2006 | 1985 |
| Country | United States | United States |
| Employees | N/A | 1677 |
| Industry | Medical/Dental Instruments | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.3B |
| IPO Year | 2016 | 1994 |
| Metric | IRTC | FIZZ |
|---|---|---|
| Price | $109.33 | $34.89 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $172.14 | N/A |
| AVG Volume (30 Days) | ★ 449.9K | 386.4K |
| Earning Date | 11-05-2026 | 09-10-2026 |
| Dividend Yield | N/A | ★ 9.47% |
| EPS Growth | ★ 61.71 | N/A |
| EPS | N/A | ★ 0.50 |
| Revenue | $747,138,000.00 | ★ $1,180,552,000.00 |
| Revenue This Year | $19.40 | $4.20 |
| Revenue Next Year | $16.65 | $1.42 |
| P/E Ratio | ★ N/A | $68.58 |
| Revenue Growth | ★ 26.24 | N/A |
| 52 Week Low | $100.70 | $28.97 |
| 52 Week High | $210.01 | $38.21 |
| Indicator | IRTC | FIZZ |
|---|---|---|
| Relative Strength Index (RSI) | 48.85 | 71.38 |
| Support Level | $107.33 | $34.23 |
| Resistance Level | $117.56 | $35.69 |
| Average True Range (ATR) | 3.63 | 0.87 |
| MACD | 0.44 | 0.58 |
| Stochastic Oscillator | 66.94 | 87.77 |
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
National Beverage Corp is refreshes America with a distinctive portfolio of sparkling waters, juices, energy drinks and, to a lesser extent, carbonated soft drinks. It focus on developing and delighting consumers with healthier beverages in response to the world-wide shift in consumer buying habits and lifestyles. The company has one reportable segment. It primary market focus is the United States. Its brands are LaCroix, Clear fruit, RIP IT, Everfresh, Shasta, Faygo, OHANA, Ritz, Crystal Bay.